| Product Code: ETC12962869 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia`s import of naltrexone and buprenorphine saw steady growth with a Compound Annual Growth Rate (CAGR) of 8.6% from 2020 to 2024. The top exporting countries to Latvia included Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the increasing growth rate of 7.03% in 2023-24, the Herfindahl-Hirschman Index (HHI) indicated low market concentration. This data suggests a competitive market environment for naltrexone and buprenorphine imports in Latvia, with diverse sources contributing to the country`s supply.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Naltrexone Buprenorphine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Latvia Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Latvia Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.6 Latvia Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Latvia Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Latvia Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.9 Latvia Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 Latvia Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of naltrexone and buprenorphine in treating opioid addiction |
4.2.2 Government initiatives to combat substance abuse and promote the use of medications like naltrexone and buprenorphine |
4.2.3 Growing research and development activities leading to the introduction of advanced formulations and delivery methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for naltrexone and buprenorphine products |
4.3.2 Limited availability of healthcare professionals trained in prescribing and managing naltrexone and buprenorphine treatment |
4.3.3 Concerns regarding the potential misuse or diversion of naltrexone and buprenorphine products |
5 Latvia Naltrexone Buprenorphine Market Trends |
6 Latvia Naltrexone Buprenorphine Market, By Types |
6.1 Latvia Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2021 - 2031F |
6.1.3 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2021 - 2031F |
6.1.4 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2021 - 2031F |
6.1.5 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2021 - 2031F |
6.1.6 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2021 - 2031F |
6.1.7 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2021 - 2031F |
6.2 Latvia Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031F |
6.2.3 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2021 - 2031F |
6.2.4 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2021 - 2031F |
6.2.5 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2021 - 2031F |
6.2.6 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2021 - 2031F |
6.3 Latvia Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2021 - 2031F |
6.3.3 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2021 - 2031F |
6.3.4 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2021 - 2031F |
6.3.5 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2021 - 2031F |
6.3.6 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.4 Latvia Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.4.4 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.5 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.6 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Latvia Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5.3 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.5.4 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.5.5 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2021 - 2031F |
6.5.6 Latvia Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2021 - 2031F |
7 Latvia Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Latvia Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Latvia Naltrexone Buprenorphine Market Imports from Major Countries |
8 Latvia Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering naltrexone and buprenorphine treatment |
8.2 Patient adherence rates to naltrexone and buprenorphine therapy |
8.3 Number of clinical trials and studies evaluating the effectiveness and safety of naltrexone and buprenorphine treatments |
9 Latvia Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Latvia Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.2 Latvia Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Latvia Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Latvia Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.5 Latvia Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
10 Latvia Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Latvia Naltrexone Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Latvia Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here